United States //   News Releases

News Releases

News Releases

Date Title and Summary Additional Formats
Toggle Summary ENDOLOGIX SUBMITS Powerlink PMA TO THE FDA
Irvine, Calif. – January 8, 2004 – Endologix, Inc. (Nasdaq: ELGX) today announced it has filed its completed pre-market approval (PMA) submission with the U.S. Food and Drug Administration (FDA) for the Powerlink® System, an endoluminal stent graft (ELG) for the minimally invasive
View HTML